
The global pharma industry will buck the trend of growing pricing pressure and deliver strong growth in profits, according to a …

Pharmaceutical companies have improved their pipelines of new drugs over the last 18 months according to financial analysts Moody’s Investors …
Credit ratings agency Moody’s believes that the travails of the past few years, when various big-selling drugs went off-patent, are …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

